Literature DB >> 25767181

Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.

Mandar S Joshi1, David Williams2, Duncan Horlock2, Thilini Samarasinghe3, Karen L Andrews4, Ann-Maree Jefferis4, Philip J Berger3, Jaye P Chin-Dusting4, David M Kaye5.   

Abstract

Microvascular complications are now recognized to play a major role in diabetic complications, and understanding the mechanisms is critical. Endothelial dysfunction occurs early in the course of the development of complications; the precise mechanisms remain poorly understood. Mitochondrial dysfunction may occur in a diabetic rat heart and may act as a source of the oxidative stress. However, the role of endothelial cell-specific mitochondrial dysfunction in diabetic vascular complications is poorly studied. Here, we studied the role of diabetes-induced abnormal endothelial mitochondrial function and the resultant endothelial dysfunction. Understanding the role of endothelial mitochondrial dysfunction in diabetic vasculature is critical in order to develop new therapies. We demonstrate that hyperglycaemia leads to mitochondrial dysfunction in microvascular endothelial cells, and that mitochondrial inhibition induces endothelial dysfunction. Additionally, we show that resveratrol acts as a protective agent; resveratrol-mediated mitochondrial protection may be used to prevent long-term diabetic cardiovascular complications.
© The Author(s) 2015.

Entities:  

Keywords:  Diabetes; cardiac dysfunction; microvascular; mitochondria; resveratrol

Mesh:

Substances:

Year:  2015        PMID: 25767181     DOI: 10.1177/1479164114565629

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  9 in total

Review 1.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

2.  Melatonin alleviates inflammation-induced apoptosis in human umbilical vein endothelial cells via suppression of Ca2+-XO-ROS-Drp1-mitochondrial fission axis by activation of AMPK/SERCA2a pathway.

Authors:  Jiasen Cui; Zeng Li; Shunjiu Zhuang; Shaohong Qi; Li Li; Junwen Zhou; Wan Zhang; Yun Zhao
Journal:  Cell Stress Chaperones       Date:  2017-09-09       Impact factor: 3.667

Review 3.  The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

Authors:  Maximillian Taro William Lee; William Mahy; Mark David Rackham
Journal:  RSC Med Chem       Date:  2021-06-04

4.  The effect of DPP-4-protected GLP-1 (7-36) on coronary microvascular function in obese adults.

Authors:  Malin Nilsson; Kira Bang Bové; Elena Suhrs; Thomas Hermann; Sten Madsbad; Jens Juul Holst; Eva Prescott; Mette Zander
Journal:  Int J Cardiol Heart Vasc       Date:  2019-01-29

5.  Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.

Authors:  Eun Nim Kim; Ji Hee Lim; Min Young Kim; Tae Hyun Ban; In-Ae Jang; Hye Eun Yoon; Cheol Whee Park; Yoon Sik Chang; Bum Soon Choi
Journal:  Aging (Albany NY)       Date:  2018-01-11       Impact factor: 5.682

6.  Evaluation of Oxidative Stress in Cardiomyocytes during the Aging Process in Rats Treated with Resveratrol.

Authors:  P Aguilar-Alonso; O Vera-López; E Brambila-Colombres; O Segura-Badilla; R Avalos-López; M Lazcano-Hernández; A R Navarro-Cruz
Journal:  Oxid Med Cell Longev       Date:  2018-05-02       Impact factor: 6.543

7.  Exosomes from hyperglycemia-stimulated vascular endothelial cells contain versican that regulate calcification/senescence in vascular smooth muscle cells.

Authors:  Shuang Li; Jun-Kun Zhan; Yan-Jiao Wang; Xiao Lin; Jia-Yu Zhong; Yi Wang; Pan Tan; Jie-Yu He; Xing-Jun Cui; Yi-Yin Chen; Wu Huang; You-Shuo Liu
Journal:  Cell Biosci       Date:  2019-01-03       Impact factor: 7.133

8.  Leptin receptor deficiency induces early, transient and hyperglycaemia-independent blood-brain barrier dysfunction.

Authors:  Noa Corem; Shira Anzi; Sivan Gelb; Ayal Ben-Zvi
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

9.  Comparison of cerebral and cutaneous microvascular dysfunction with the development of type 1 diabetes.

Authors:  Wei Feng; Shaojun Liu; Chao Zhang; Qing Xia; Tingting Yu; Dan Zhu
Journal:  Theranostics       Date:  2019-08-12       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.